Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Completed × Parasomnias × Clear all

Phase

Phase NA 18 Phase 3 2 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1118 Carcinoma, Non-Small-Cell Lung 796 Prostatic Neoplasms 645 Neoplasms 537 Lymphoma 473 Multiple Myeloma 472 Colorectal Neoplasms 471 Lung Neoplasms 465 Leukemia 431 Neoplasm Metastasis 414 Leukemia, Myeloid, Acute 406 Melanoma 382 Lymphoma, Non-Hodgkin 362 Ovarian Neoplasms 353 Leukemia, Lymphocytic, Chronic, B-Cell 335 Pancreatic Neoplasms 326 Recurrence 298 Precursor Cell Lymphoblastic Leukemia-Lymphoma 277 Head and Neck Neoplasms 264 Glioblastoma 264 Lymphoma, Large B-Cell, Diffuse 258 Brain Neoplasms 255 Stomach Neoplasms 251 Myelodysplastic Syndromes 248 Lymphoma, Follicular 246 Carcinoma, Renal Cell 233 Hodgkin Disease 227 Rectal Neoplasms 226 Carcinoma, Hepatocellular 225 Sarcoma 220

Interventions

nabiximols 1 Dronabinol 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡